Hepatocellular Carcinoma News and Research

RSS
NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Researchers discover relationship between TGFb signalling pathways and CXCR4 in HCC

Researchers discover relationship between TGFb signalling pathways and CXCR4 in HCC

Polaris Group reports positive results from ADI-PEG 20 Phase 2 trial for malignant pleural mesothelioma

Polaris Group reports positive results from ADI-PEG 20 Phase 2 trial for malignant pleural mesothelioma

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

Three cups of coffee per day reduce liver cancer risk by more than 50%

Three cups of coffee per day reduce liver cancer risk by more than 50%

Guerbet receives FDA Orphan Drug Designation for Lipiodol Injection

Guerbet receives FDA Orphan Drug Designation for Lipiodol Injection

Scientists find that activating family of small protein could suppress liver malignancies

Scientists find that activating family of small protein could suppress liver malignancies

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

GenSpera to present G-202 Phase I trial in hepatocellular carcinoma at EORTC-NCI-AACR Symposium

HBV-infected men more likely to develop liver cancer

HBV-infected men more likely to develop liver cancer

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

Researchers find ways to identify, isolate HCC progenitor cells before tumors become evident

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

Peru: Liver cancer affects young people and children who do not have related risk factors

Peru: Liver cancer affects young people and children who do not have related risk factors

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

Research findings could lead to new therapeutic approaches for liver cancer

Research findings could lead to new therapeutic approaches for liver cancer

Virttu Biologics treats first cohort of patients in SEPREHVIR Phase I/IIa study

Virttu Biologics treats first cohort of patients in SEPREHVIR Phase I/IIa study

FDA grants Priority Review designation to sNDA for Nexavar tablets

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Research findings could enable early screening of HCC patients for more aggressive treatment

Research findings could enable early screening of HCC patients for more aggressive treatment

Research could enable early screening of liver cancer patients to improve survival rate

Research could enable early screening of liver cancer patients to improve survival rate

Researchers develop RNA aptamers that inhibit HCV replication

Researchers develop RNA aptamers that inhibit HCV replication

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.